title: Prognostic significance of monitoring leukemia-associated immunophenotypes by eight-color flow cytometry in adult B-acute lymphoblastic leukemia.
abstract: Minimal residual disease (MRD) is of the most important factor for predicting prognosis and guiding treatment of acute lymphoblastic leukemia (ALL). In this study, we investigated the prognostic significance of leukemia-associated immunophenotypes (LAIPs) as assessment of index of MRD in 125 adult B-lineage ALL (B-ALL) patients by eight-color flow cytometry. The LAIPs could be identified in 96% and 81.6% of patients with the sensitivity of 10(-4) and 10(-5), respectively. MRD-negative status could clearly predict a favorable 2-year relapse-free survival (RFS) and overall survival (OS) at the end of induction of complete remission and one cycle of consolidation treatment. Moreover, we identified a group of cases with MRD of 0.001% to <0.01%, which showed significantly higher 2-year relapse rate than those with undetectable one. In multivariate analysis, MRD status was associated with RFS or OS independently. Furthermore, MRD assessed by LAIPs and RQ-PCR assay for patients with BCR-ABL fusion gene yielded concordant results in 89.7% of cases. In conclusion, MRD evaluated by eight-color flow cytometry could provide an important tool to assess treatment response and prognosis precisely in adult B-ALL.
authors: State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
authors: X-Q
authors: XQ
authors: Weng
authors: Y
authors: Y
authors: Shen
authors: Y
authors: Y
authors: Sheng
authors: B
authors: B
authors: Chen
authors: J-H
authors: JH
authors: Wang
authors: J-M
authors: JM
authors: Li
authors: J-Q
authors: JQ
authors: Mi
authors: Q-S
authors: QS
authors: Chen
authors: Y-M
authors: YM
authors: Zhu
authors: C-L
authors: CL
authors: Jiang
authors: H
authors: H
authors: Yan
authors: X-X
authors: XX
authors: Zhang
authors: T
authors: T
authors: Huang
authors: Z
authors: Z
authors: Zhu
authors: Z
authors: Z
authors: Chen
authors: S-J
authors: SJ
authors: Chen
references: Blood. 2012 Aug 30;120(9):1868-76
references: 22442346
references: Leukemia. 2003 Dec;17(12):2257-317
references: 14671650
references: Hematology Am Soc Hematol Educ Program. 2010;2010:7-12
references: 21239764
references: Blood. 2003 Jun 15;101(12):4695-700
references: 12586618
references: Blood. 2001 Oct 15;98(8):2498-507
references: 11588048
references: Leukemia. 2010 Mar;24(3):521-35
references: 20033054
references: Curr Oncol Rep. 2012 Oct;14(5):387-94
references: 22669492
references: Lancet. 1998 Nov 28;352(9142):1731-8
references: 9848348
references: Blood. 2002 Mar 15;99(6):1952-8
references: 11877265
references: Best Pract Res Clin Haematol. 2002 Dec;15(4):639-52
references: 12617868
references: Hematol Oncol Clin North Am. 2009 Oct;23(5):1083-98, vii
references: 19825454
references: Arch Pathol Lab Med. 2006 May;130(5):680-90
references: 16683886
references: Br J Haematol. 1999 Apr;105(1):241-55
references: 10233388
references: Blood. 2002 Jul 1;100(1):52-8
references: 12070008
references: Br J Haematol. 2008 Jun;142(2):227-37
references: 18492099
references: Leukemia. 2003 Dec;17(12):2474-86
references: 14562124
references: Blood. 2011 Jun 9;117(23):6267-76
references: 21487112
references: Leukemia. 2013 Mar;27(3):635-41
references: 22945774
references: Blood. 2000 Oct 15;96(8):2691-6
references: 11023499
references: Blood. 2008 Jun 15;111(12):5477-85
references: 18388178
references: Leukemia. 2004 Oct;18(10):1630-6
references: 15295608
references: Cytometry. 1999 Aug 15;38(4):139-52
references: 10440852
references: Leukemia. 1999 Mar;13(3):419-27
references: 10086733
references: Leukemia. 2001 Aug;15(8):1185-92
references: 11480560
references: Blood. 2010 Apr 22;115(16):3206-14
references: 20154213
references: Leukemia. 1999 Jan;13(1):110-8
references: 10049045
references: N Engl J Med. 1998 Aug 27;339(9):591-8
references: 9718378
references: Cytometry B Clin Cytom. 2008 Nov;74(6):331-40
references: 18548617
references: Leukemia. 2003 Dec;17(12):2318-57
references: 14562125
references: Br J Haematol. 2005 Mar;128(6):774-82
references: 15755280
references: Blood. 2007 Feb 1;109(3):926-35
references: 17003380
references: Leukemia. 2012 Sep;26(9):1908-75
references: 22552007
references: Leukemia. 2012 Jul;26(7):1507-16
references: 22297722
references: Front Med. 2012 Jun;6(2):204-11
references: 22660978
references: Blood. 2006 Feb 1;107(3):1116-23
references: 16195338
references: Leukemia. 2012 Sep;26(9):1986-2010
references: 22948490
references: Leukemia. 2013 Feb;27(2):370-6
references: 23070018
references: Cytometry A. 2012 Jan;81(1):17-24
references: 22052678
references: N Engl J Med. 2009 Jun 25;360(26):2730-41
references: 19553647
references: Blood. 2011 Aug 25;118(8):2077-84
references: 21719599
references: Leukemia. 2001 Sep;15(9):1415-23
references: 11516102
references: Hematology Am Soc Hematol Educ Program. 2011;2011:231-7
references: 22160039
references: Leukemia. 2000 Aug;14(8):1419-25
references: 10942238
references: Leukemia. 2012 Jul;26(7):1608-16
references: 22382891
references: Leukemia. 2003 Jan;17(1):138-48
references: 12529671
references: Blood. 2007 Feb 1;109(3):910-5
references: 17023577
references: Leukemia. 2007 Apr;21(4):604-11
references: 17287850
references: Leukemia. 2004 May;18(5):934-8
references: 15029212
references: Blood. 2012 Nov 29;120(23):4470-81
references: 23033265